Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood-Brain Barrier (3B) for Brain Tumor

被引:3
作者
Jindal, Amulya [1 ,2 ]
Mainuddin [1 ,3 ]
Kumar, Anoop [1 ]
Ratnesh, Ratneshwar Kumar [4 ]
Singh, Jay [5 ]
机构
[1] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut 250005, Uttar Pradesh, India
[2] SRM Inst Sci & Technol, SRM Modinagar Coll Pharm, Delhi NCR Campus, Ghaziabad 201204, Uttar Pradesh, India
[3] Amity Univ, Dept Pharmaceut, Amity Inst Pharm, Sect 125, Noida 201301, Uttar Pradesh, India
[4] Meerut Inst Engn & Technol, Dept Elect & Commun Engn, Meerut 250005, Uttar Pradesh, India
[5] Banaras Hindu Univ, Inst Sci, Dept Chem, Varanasi 221005, Uttar Pradesh, India
关键词
Glioblastoma; Nanotechnology; Blood-brain barrier; Targeted system; Lipid based drug carrier; PEGYLATED LIPOSOMAL DOXORUBICIN; MESOPOROUS SILICA NANOPARTICLES; DRUG-DELIVERY; FOCUSED ULTRASOUND; COMBINATION THERAPY; QUANTUM DOTS; SOLID TUMORS; IN-VITRO; CANCER; GLIOBLASTOMA;
D O I
10.1007/s12088-024-01330-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The evolution of nanotechnology-driven lipid and metalloid-based nanoformulations has garnered significant attention for developing effective drug delivery systems with position/time precision and efficacy. This study focuses on challenges of blood-brain barrier (BBB) and their pivotal role in drug targeting in chronic diseases such as brain tumors (BTs). These formulations encapsulate therapeutic agents within lipidic matrices, enhancing drug solubility, bioavailability, and targeted delivery. The diverse lipid materials used in these nanoformulations highlight their biocompatibility and versatility, covering a wide range of drugs. Emphasis is placed on metal nanoparticles, liposomes, ethosomes, quantum dots, carbon nanotubes, nanorobots, and micelles. The analysis explores their drug loading, stability, release characteristics, and bioavailability modulation. It also delves into the enhanced-permeability and retention (EPR) effect, crucial for passive targeting of tumors. Recent nanocarrier systems enable better penetration of therapeutic compounds through the BBB, addressing treatment failures in invasive BTs.This review highlights the latest nanotechnology developments and potential therapeutic approaches, serving as a valuable resource for researchers, clinicians, and pharmaceutical scientists.
引用
收藏
页码:92 / 119
页数:28
相关论文
共 145 条
  • [1] Liposome: classification, preparation, and applications
    Akbarzadeh, Abolfazl
    Rezaei-Sadabady, Rogaie
    Davaran, Soodabeh
    Joo, Sang Woo
    Zarghami, Nosratollah
    Hanifehpour, Younes
    Samiei, Mohammad
    Kouhi, Mohammad
    Nejati-Koshki, Kazem
    [J]. NANOSCALE RESEARCH LETTERS, 2013, 8
  • [2] lmmunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells
    Alizadeh, Darya
    White, Ethan E.
    Sanchez, Teresa C.
    Liu, Shunan
    Zhang, Leying
    Badie, Behnam
    Berlin, Jacob M.
    [J]. BIOCONJUGATE CHEMISTRY, 2018, 29 (05) : 1659 - 1668
  • [3] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [4] Development and optimization of oral nanoemulsion of rutin for enhancing its dissolution rate, permeability, and oral bioavailability
    Alshahrani, Saad M.
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2022, 27 (05) : 588 - 597
  • [5] Anti-angiogenic therapy for high-grade glioma (Review)
    Ameratunga, Malaka
    Pavlakis, Nick
    Wheeler, Helen
    Grant, Robin
    Simes, John
    Khasraw, Mustafa
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (11):
  • [6] RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo (Retracted article. See vol. 102, pg. 143, 2016)
    Anand, Preetha
    Nair, Hareesh B.
    Sung, Bokyung
    Kunnumakkara, Ajaikumar B.
    Yadav, Vivek R.
    Tekmal, Rajeshwar R.
    Aggarwal, Bharat B.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2010, 79 (03) : 330 - 338
  • [7] Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
    Anraku, Y.
    Kuwahara, H.
    Fukusato, Y.
    Mizoguchi, A.
    Ishii, T.
    Nitta, K.
    Matsumoto, Y.
    Toh, K.
    Miyata, K.
    Uchida, S.
    Nishina, K.
    Osada, K.
    Itaka, K.
    Nishiyama, N.
    Mizusawa, H.
    Yamasoba, T.
    Yokota, T.
    Kataoka, K.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [8] Iron Oxide Incorporated Conjugated Polymer Nanoparticles for Simultaneous Use in Magnetic Resonance and Fluorescent Imaging of Brain Tumors
    Arias-Ramos, Nuria
    Ibarra, Luis Exequiel
    Serrano-Torres, Maria
    Yague, Balbino
    Caverzan, Matias Daniel
    Chesta, Carlos Alberto
    Palacios, Rodrigo Emiliano
    Lopez-Larrubia, Pilar
    [J]. PHARMACEUTICS, 2021, 13 (08)
  • [9] Pericytes regulate the blood-brain barrier
    Armulik, Annika
    Genove, Guillem
    Mae, Maarja
    Nisancioglu, Maya H.
    Wallgard, Elisabet
    Niaudet, Colin
    He, Liqun
    Norlin, Jenny
    Lindblom, Per
    Strittmatter, Karin
    Johansson, Bengt R.
    Betsholtz, Christer
    [J]. NATURE, 2010, 468 (7323) : 557 - U231
  • [10] A Comprehensive Review on Plant-Based Medications and Chemical Approaches for Autism Spectrum Disorders (ASDs) Psychopharmacotherapy
    Ashwlayan, Vrish Dhwaj
    Ratnesh, Ratneshwar Kumar
    Sharma, Divya
    Sharma, Alok
    Sangal, Akansha
    Saifi, Alimuddin
    Singh, Jay
    [J]. INDIAN JOURNAL OF MICROBIOLOGY, 2024, 65 (1) : 15 - 31